Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

TSRI scientists show that rare genetic mutations increase susceptibility to sepsis

29.04.2003


A group of researchers from The Scripps Research Institute (TSRI) have discovered rare genetic mutations in a subset of people who come down with a particular kind of severe sepsis, an acute and often deadly disease.



These rare mutations in a human gene called TLR4 lend susceptibility to meningococcal sepsis, which strikes over 2,500 people a year in the United States. About half of those who contract meningococcal sepsis are younger than the age of two, and the disease has an overall case fatality rate of 12 percent.

"It’s a very fast-moving, dramatic, and often fatal disease," says TSRI Immunology Professor Bruce Beutler, who led the research, which will be published in an upcoming issue of the journal Proceedings of the National Academy of Sciences.


"We took a large number of people with meningococcal sepsis and compared them to normal controls who were ethnically and geographically matched," says Beutler. "We found that the TLR4 gene had more mutations in the sepsis populations."

Besides demonstrating that the risk of severe sepsis increases with these mutations, which can be passed from parent to child, the study also suggests that it may be possible to protect people who are at risk. While not practical at the moment, eventually patients with mutations to their TLR4 genes might be given prophylactic treatment, for instance, before they undergo surgery or travel somewhere they are likely to be exposed to meningococcal bacteria.

Blinding the Immune System

Scientists had suspected that genetic factors determine who gets the severe form of the disease and who does not. Evidence for this was seen during outbreaks of this disease, when the severe and deadly form of sepsis was more likely to strike related individuals.

Further evidence was seen in mice, and it was known for years that certain strains of mice are more susceptible to infections with bacteria like N. meningitides--but nobody had ever shown this to be true in humans. Now, the TSRI team found a number of rare mutations in one essential gene in the innate immune system called Toll-like receptor 4 (TLR4), which is important in endotoxin recognition, giving people a higher probability of contracting meningococcal sepsis.

TLR4 is part of the mammalian endotoxin receptor and is an important gene because it detects the early stages of a bacterial infection. It is a powerful pro-inflammatory receptor, responsible for activating the immune system to attack invading gram-negative bacteria like N. meningitidis. During a mammalian innate immune response, TLR4 recognizes endotoxins from the bacteria and activates macrophages, which then ingest and destroy the foreign pathogens.

"The TLRs are the eyes of the innate immune system," says Beutler, who had suspected that these eyes may be myopic for some people and that mutations in the TLR4 gene may underlie the genetic component of severe sepsis.

In order to address this, Beutler looked for extremely rare mutations in the gene by obtaining hundreds of samples of DNA from his collaborator Martin L. Hibberd, then a doctor at Imperial College in London (Hibberd has since taken a position at the Genome Institute of Singapore). He then amplified and sequenced the entire TLR4 gene from each patient, looking for all the rare mutations that are present in the gene--rather than taking the traditional approach of looking at one common mutation within that gene.

After the researchers had analyzed all the genetic information, they found a significant excess of low frequency mutations in the TLR4 genes of the people who had contracted sepsis versus the control group.

Instead of asking how many people have one given mutation, Beutler and his colleagues simply asked how many people have any genetic variation. A few individuals had the same mutations, but by and large they were single, isolated mutations. "However," warns Beutler, "we can only account for a certain fraction of the [genetic] risk."

Nevertheless, this is the first time that a comparison of the collective mutations at a given genetic locus has been made in any infectious disease. Infectious diseases are, after all, primarily caused by an invading organism, and only in recent times has a concerted effort been made to find genetic determinants of susceptibility in the patient. Beutler and his team had to write special software to make the comparison of the thousand different sequences possible and find the individual mutations therein. Significantly, the technique of measuring the genetic variation “load” of the entire gene locus could be applied to other sorts of diseases as well: particularly diseases in which both genes and environment play a role.



The article, "Assay Of Locus-Specific Genetic Load Implicates Rare Tlr4 Mutations in Meningococcal Susceptibility," is authored by Irina Smirnova, Navjiwan Mann, Annemiek Dols, H. H. Derkx, Martin L. Hibberd, Michael Levin, and Bruce Beutler. The article will be available online the week of April 28, 2003 at: http://www.pnas.org/cgi/doi/10.1073/pnas.10311605100, and will be published in an upcoming issue of the journal Proceedings of the National Academy of Sciences. Journalists can request a preprint of the paper from pnasnews@nas.edu.


This work was supported by The National Institutes of Health and also by the Meningitis Research Foundation, a United Kingdom charity.

Jason Bardi | EurekAlert!
Further information:
http://www.scripps.edu/
http://www.pnas.org/cgi/doi/10.1073/pnas.10311605100

More articles from Health and Medicine:

nachricht New leukemia treatment offers hope
23.09.2016 | King Abdullah University of Science and Technology

nachricht Alzheimer’s: Cellular Mechanism Provides Explanation Model for Declining Memory Performance
21.09.2016 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: OLED microdisplays in data glasses for improved human-machine interaction

The Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP has been developing various applications for OLED microdisplays based on organic semiconductors. By integrating the capabilities of an image sensor directly into the microdisplay, eye movements can be recorded by the smart glasses and utilized for guidance and control functions, as one example. The new design will be debuted at Augmented World Expo Europe (AWE) in Berlin at Booth B25, October 18th – 19th.

“Augmented-reality” and “wearables” have become terms we encounter almost daily. Both can make daily life a little simpler and provide valuable assistance for...

Im Focus: Artificial Intelligence Helps in the Discovery of New Materials

With the help of artificial intelligence, chemists from the University of Basel in Switzerland have computed the characteristics of about two million crystals made up of four chemical elements. The researchers were able to identify 90 previously unknown thermodynamically stable crystals that can be regarded as new materials. They report on their findings in the scientific journal Physical Review Letters.

Elpasolite is a glassy, transparent, shiny and soft mineral with a cubic crystal structure. First discovered in El Paso County (Colorado, USA), it can also be...

Im Focus: Complex hardmetal tools out of the 3D printer

For the first time, Fraunhofer IKTS shows additively manufactured hardmetal tools at WorldPM 2016 in Hamburg. Mechanical, chemical as well as a high heat resistance and extreme hardness are required from tools that are used in mechanical and automotive engineering or in plastics and building materials industry. Researchers at the Fraunhofer Institute for Ceramic Technologies and Systems IKTS in Dresden managed the production of complex hardmetal tools via 3D printing in a quality that are in no way inferior to conventionally produced high-performance tools.

Fraunhofer IKTS counts decades of proven expertise in the development of hardmetals. To date, reliable cutting, drilling, pressing and stamping tools made of...

Im Focus: Launch of New Industry Working Group for Process Control in Laser Material Processing

At AKL’16, the International Laser Technology Congress held in May this year, interest in the topic of process control was greater than expected. Appropriately, the event was also used to launch the Industry Working Group for Process Control in Laser Material Processing. The group provides a forum for representatives from industry and research to initiate pre-competitive projects and discuss issues such as standards, potential cost savings and feasibility.

In the age of industry 4.0, laser technology is firmly established within manufacturing. A wide variety of laser techniques – from USP ablation and additive...

Im Focus: New laser joining technologies at ‘K 2016’ trade fair

Every three years, the plastics industry gathers at K, the international trade fair for plastics and rubber in Düsseldorf. The Fraunhofer Institute for Laser Technology ILT will also be attending again and presenting many innovative technologies, such as for joining plastics and metals using ultrashort pulse lasers. From October 19 to 26, you can find the Fraunhofer ILT at the joint Fraunhofer booth SC01 in Hall 7.

K is the world’s largest trade fair for the plastics and rubber industry. As in previous years, the organizers are expecting 3,000 exhibitors and more than...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Experts from industry and academia discuss the future mobile telecommunications standard 5G

23.09.2016 | Event News

ICPE in Graz for the seventh time

20.09.2016 | Event News

Using mathematical models to understand our brain

16.09.2016 | Event News

 
Latest News

Chains of nanogold – forged with atomic precision

23.09.2016 | Life Sciences

New leukemia treatment offers hope

23.09.2016 | Health and Medicine

Self-assembled nanostructures hit their target

23.09.2016 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>